Taj recognizes that the ultimate goal of
API synthesis is to scale-up from milligram quantities at the lab
bench to kilogram quantities in a pilot plant. We also understand that
at the clinical supply stage, process development becomes increasingly
complex. With over 220 combined years of experience at our Oxford, UK,
site, 180 years at our Missouri, US, site, and over 170 years' process
chemistry experience in our senior staff in India, Taj's chemists are
recognized as experts in process optimization for API scale up, as
well as for novel route development. Taj's Oxford and Missouri
facilities have been FDA inspected, and, additionally, the MHRA has
inspected and approved the UK site.
At Taj, we can help you deal quickly and
safely with the challenges and complexities of scale-up. Our staff and
facilities work toward an API synthesis process that is:
- Robust
- Quick
- Transferable
- Cost-effective
- Safe
Our goal is to help you lock in your
process parameters so that they may be transferred to any other
facility as the product evolves in development. We can also produce
batches of API, scaled to the specific demands of clinical trials.
India